A clinical study on siddha trial drug manjanaathi kudineer chooranam in children having acute nasopharyngitis

An open clinical study on neerkana mantham(acute nasopharynngitis) in children with the evaluation of siddha trial drug manjanaathi kudineer chooranam

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015380

Enrollment

Registered

2018-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold] Health Condition 2: J00-J99- Diseases of the respiratory system

Interventions

Intervention1: Manjanaathi kudineer chooranam: 8grams of manjanaathi kudineer chooranam twice a day for 7days as internal medicine Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Running nose, Cough, Fever, Malaise

Exclusion criteria

Exclusion criteria: Allergic rhinitis, Bronchitis, Bronchial asthma, Rheumatic fever, Tonsilitis

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by comparing the reduction in clinical symptoms (like running nose, fever, cough, malaise) and recurrence in before and after treatmentTimepoint: Nil	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Meenakumari

Government siddha medical college

dr.meenakumari.km@gmail.com9176534465

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026